Avalyn Pharma Inc share price logo

Avalyn Pharma Inc

NASDAQ: AVLN

Small Cap

$34.28

-0.70

(-2.00%)

as on

Avalyn Pharma Inc Stock Performance

as on September 16, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $32.59
    $35.53
    downward going graph

    4.93%

    Downside

    3.65%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Avalyn Pharma Inc share price movements today

Previous Close
$34.98
Open
$35.13
Volume
375.2K
Market Cap
$1.5B
Day's Low - High
$32.59 - $35.53

Avalyn Pharma Inc Historical Returns

1 Month Return
-10.88 %
3 Month Return
+ 21.67 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Avalyn Pharma Inc Stock Fundamentals & Key Indicators

Check Avalyn Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-1.29

Dividend Yield

0.00%

PE Ratio (TTM)

-26.02

Industry PE ratio

-6.33

PEG Ratio

-0.2602325581395349

Return On Equity TTM

-83.23%

Avalyn Pharma Inc Stock Valuation

Track how Avalyn Pharma Inc P/E has moved over time to understand its valuation trends.

Avalyn Pharma Inc in the last 1 year

  • Overview

  • Trends

Lowest (-14.46x)

December 31, 2025

Today (-14.46x)

December 31, 2025

Industry (-6.33x)

December 31, 2025

Highest (-14.46x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -14.46x

Avalyn Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Avalyn Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.5BNA-26.020.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$130.6B175.08%29.7686.04%NA
BUY$57.5B-66.24%-18.04-12.57%NA
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Analyst Recommendation on Avalyn Pharma Inc Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Avalyn Pharma Inc. Average target price of $54.5

Indian Investors' Interest in Avalyn Pharma Inc Stock

Search interest for Avalyn Pharma Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-67% versus previous 30 day period

Avalyn Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2026
Jun 2026
Total Revenue
-
-
Gross Profit
-
0
Operating Income
-27
-31
EBITDA
-26
-31
Interest Expense
0
0
Depreciation
0
0
Income Before Tax
-26
-28
Income Tax Expense
-
-
Net Income
-26
-28
Net Profit Margin
0.00%
0.00%

Avalyn Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2025
Total Revenue
-
Gross Profit
-
Operating Income
-91
EBITDA
-91
Interest Expense
-
Depreciation
0
Income Before Tax
-85
Income Tax Expense
-
Net Income
-85
Net Profit Margin
0.00%

Avalyn Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2026
Jun 2026
Net Income
-26
-28
Operating Cash Flow
-29
-26
Investing Cash Flow
55
-118
Financing Cash Flow
14
316
Change in Cash
39
171

Avalyn Pharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-85
Operating Cash Flow
-81
Investing Cash Flow
10
Financing Cash Flow
99
Change in Cash
28

Global Institutional Holdings in Avalyn Pharma Inc

Funds
Holdings
Joseph Edelman
6.03%
Vanguard
1.9%
James E. Flynn
1.65%
iShares
1.36%
Felix Baker
0.79%

Avalyn Pharma Inc News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 05:30 PM

    -

    Avalyn Pharma to participate in Morgan Stanley Healthcare Conference on September 14, 2026, discussing inhaled therapies for respiratory diseases.

Insights on Avalyn Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, AVLN stock has moved up by 22.1%

About Avalyn Pharma Inc

Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose combination of inhaled pirfenidone and nintedanib to deliver dual antifibrotic mechanisms. Avalyn Pharma Inc. was formerly known as Genoa Pharmaceuticals, Inc. and changed its name to Avalyn Pharma Inc. in July 2017. The company was incorporated in 2011 and is based in Boston, Massachusetts.
OrganisationAvalyn Pharma Inc
Headquarters105 W First Street, Boston, MA, United States, 02127
IndustryBiotechnology
CEOMs. Lyn Baranowski
E-voting on sharesClick here to vote

Key Management of Avalyn Pharma Inc

Name

Title

Mr. Douglas R. Carlson

CFO & Chief Business Officer

Dr. Melissa Rhodes DABT, Ph.D.

Chief Operating Officer

Mr. Adam H, Golden J.D.

General Counsel & Head of Business Development

Ms. Michelle Patterson M.B.A., P.M.P.

Senior Vice President of Corporate Planning & Portfolio Strategy

Ms. Lyn Baranowski

CEO, President & Director

Dr. Howard M. Lazarus M.D.

Chief Medical Officer

Ms. Cassie Saitow

Senior Director of IR & Corporate Communications

Dr. Craig Conoscenti M.D.

Senior Vice President of Clinical Development

Mr. James Bishop

Senior Vice President of Business Operations

Dr. Stephen Pham Ph.D.

Senior Vice President of Product Development

FAQs

What is Avalyn Pharma Inc share price today?

Avalyn Pharma Inc share price today is $34.28 as on at the close of the market. Avalyn Pharma Inc share today touched a day high of $35.53 and a low of $32.59.

What is the 52 week high and 52 week low for Avalyn Pharma Inc share?

Avalyn Pharma Inc share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Avalyn Pharma Inc stock price today i.e. is closed at $34.28,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Avalyn Pharma Inc's market capitalisation today?

Avalyn Pharma Inc market capitalisation is $0.00T as on .

How to invest in Avalyn Pharma Inc Stock (AVLN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Avalyn Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avalyn Pharma Inc Shares that will get you 0.0438 shares as per Avalyn Pharma Inc share price of $34.28 per share as on September 16, 2026 at 8:46 am IST.

What is the minimum amount required to buy Avalyn Pharma Inc Stock (AVLN) from India?

Indian investors can start investing in Avalyn Pharma Inc (AVLN) shares with as little as ₹95.94 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.40 in Avalyn Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Avalyn Pharma Inc share’s latest price of $34.28 as on September 16, 2026 at 8:46 am IST, you will get 0.2917 shares of Avalyn Pharma Inc. Learn more about fractional shares .